MAIA CIK: 1878313

MAIA Biotechnology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
10.7
FY22:
11.8
FY23:
7.56
FY24:
10.2
FY25:
9.70
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.65
FY22:
0.21
FY23:
0.00
FY24:
0.00
FY25:
0.00
Total assets
Change from FY21 to FY25
millions USD
FY21:
11.3
FY22:
12.0
FY23:
7.57
FY24:
10.2
FY25:
9.70

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.15
FY22:
3.27
FY23:
4.94
FY24:
3.83
FY25:
5.84
(negative)
millions USD
FY21:
0
FY22:
0.25
FY23:
2.15
FY24:
2.69
FY25:
1.49
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.18
FY22:
8.51
FY23:
0.48
FY24:
3.63
FY25:
2.38
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
11.3
FY22:
12.0
FY23:
7.57
FY24:
10.2
FY25:
9.70

All amounts in millions USD Data source:SEC EDGAR